Drug intelligence / Profile preview

Luarprofen

Development stage
Preclinical
Lead developer
Química Luar
Modality
Small Molecules
Administration
Inhalation
01

Overview

Luarprofen is an innovative inhaled and nebulizable pharmaceutical formulation of ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), developed by Química Luar SRL and CEPROCOR. It is designed for the potential treatment of pulmonary affections, particularly to reduce the severity and progression of lung injury and inflammation in patients with severe acute respiratory syndrome due to SARS-CoV-2 (COVID-19). Ibuprofen exerts its therapeutic effects by non-selectively inhibiting cyclooxygenase (COX) enzymes, COX-1 and COX-2, thereby decreasing the synthesis of prostaglandins which are key mediators of inflammation, pain, and fever.

Brand names
Luarprofen
Other names
Inhalable ibuprofenNebulizable ibuprofenInhaled Hypertonic ibuprofenlipid ibuprofen
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Luarprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luarprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call